Processing and Ligand-Induced Modifications of the V2 Vasopressin Receptor
Synthesis, processing and agonist-induced modifications of the V2 vasopressin receptor were examined in stably or transiently transfected HEK293 cells. Metabolic labeling with35S methionine for 30 min revealed a predominant precursor protein which subsequently gave rise to the mature receptor on the cell surface. Maturation of the receptor was unrelated to glycosylation suggesting that it was the consequence of protein refolding. In addition to monomeric forms of V2 receptor protein, oligomers of the precursor protein were also detected in SDS-PAGE. These oligomers seemed to be dimers and tetrameres, and were more apparent in transiently transfected cells that produced higher quantities of protein then stably transfected cells. No oligomers of the mature receptor were detected, and co-transfection of the wild type with a mutant V2 receptor lacking G-protein coupling activity did not alter the function of the wild type receptor. These results indicated that the formation of oligomeric was most likely a consequence of overproduction of the protein and not a required step for receptor function.
Addition of vasopressin promoted phosphorylation and sequestration of the wild type receptor, and of the R137H mutant receptor which lacks coupling to G proteins. Activation of protein kinases A or C did not result in phosphorylation of un-occupied receptor. Phosphate incorporated into the protein was stable in the continuous presence of the ligand despite sequestration of the receptor protein. Deletion of the last 14 amino acids abolished receptor phosphorylation but not sequestration and desensitization, indicating that these two processes are not dependent on protein phosphorylation. Additionally, phosphorylation and sequestration of the R137H mutant receptor revealed that phosphorylation and sequestration does not require coupling to Gs.
KeywordsPalmitic Acid Adenylyl Cyclase Activity Nephrogenic Diabetes Insipidus Wild Type Receptor Mature Receptor
Unable to display preview. Download preview PDF.
- 6.Bichet DG, Birnbaumer M, Lonergan M, Arthus M-F, Rosenthal W, Goodyer P, Nivet H, Benoit S, Giampietro P, Simonetti S, Fish A, Whitley CB, Jaeger P, Gertner J, New M, DiBona F, Kaplan BS, Robertson GL, Hendy GN, Fujiwara TM, Morgan K. 1994 Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus. Am J Huni Gen 55:278–286.Google Scholar
- 16.Schuelein R, Liebenhoff U, Mueller H, Birnbaumer M, Rosenthal W. 1996 Properties of the human vasopressin V2 receptor after site-directed mutagenesis of its putative palmitoylation site. Biochem. J. 313:611–616.Google Scholar
- 17.Sadeghi H, Innamorati G, Dagarag M, Birnbaumer M. 1997 Role of palmitoylation in V2 vasopressin receptor expression. Mol. Pharmacol, in press.Google Scholar
- 19.Seibold A, Dagarag M, Birnbaumer M. 1997 Coupling of the 132-adrenergic receptor altered at the DRY motif. Receptors and Channels, in press.Google Scholar